As a physician anesthesiologist, I see patients taking a GLP-1, like Ozempic, Wegovy, or Zepbound, every single day. Use of these drugs, originally intended for diabetes, has skyrocketed as people take them for weight loss, sleep apnea, and cardiovascular health. There is still much to learn about these medications, but we know they present challenges […]

More than 3 million adults in Ohio (nearly 37% of our population!) live with obesity. This is not a personal failing; it is a complex, chronic disease crisis that is worsening each year and demands a focused, statewide intervention. Fortunately, we are entering an era of unprecedented medical advancement. The advent of GLP-1 receptor agonists is a […]